Direxion Daily S&P Biotech Bear 3X ETF
LABD
LABD
11 hedge funds and large institutions have $13.8M invested in Direxion Daily S&P Biotech Bear 3X ETF in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
13% less capital invested
Capital invested by funds: $15.8M → $13.8M (-$2.08M)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Holders
11
Holding in Top 10
–
Calls
$24.7M
Puts
$10.4M
Top Buyers
| 1 | +$779K | |
| 2 | +$535K | |
| 3 | +$350K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$320K |
| 5 |
Morgan Stanley
New York
|
+$84.2K |
Top Sellers
| 1 | -$1.9M | |
| 2 | -$952K | |
| 3 | -$392K | |
| 4 |
MMA
Miracle Mile Advisors
Los Angeles,
California
|
-$359K |
| 5 |
Citigroup
New York
|
-$244K |